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determinants of poet Ml cardiovascular drug use including nationality. Sig-
nificant differences exiatad between patient groups treated within the United
States (US) and other nations (NUS) (Europe, Canada&Australia). The US
group had a greater proportion of females, hypertensive (HTN), diabetica
and patients with prior bypass surgery (all p c 0.002). No differeneas wera
notad in age, time to treatment, recurrent ischemia or ra-infarction (all p >
0.05). The last ESVI before hospital discharge was significantly smaller in
US patienta compared to NUS (p -=0.0001). Multivariable analysis identified
determinants of long term cardiovascular drug use listad below according to
rank. (p value).
ACE Calcium Blwcker Bets Blocker Vasodilators
tESVl (0.0001) HTN (0.0001) NUS (0.0001) NUS
HTN (0.0001) us (0.0002) NoCHF (0.0001) Smoker (0.09)
CHF (0.0001) JESVI (0.02) HTN (0.002) Female (0,01)
NUS (0.0001) NoCHF (0.03) Age <75 (0.002) -
Diabetee (0.001) Smoker (0.03) ~Lipids (0.05) -
Female (0.01) - $ESVI (0.009) -
Conclusions.’ 1). Long term post Ml drug use is in pari dependent on
nation specific practice patterns after correction for specific drug indications.
2). US patients are less likely to receive ACE inhibitors or bate blockers than
NUS patients post Ml. The etiology of these differences is unknown. The
‘global community” is not yet a madicsl reality regarding post Ml medical
therapy.
m1078127 T WavaChangeaAftarReperfuesdAcuteMyocardialinfarction:A Markerof infarctSiza
T. Onodera, A. Takizawa, M.-S. Kim, H. Fukita, A. Uehara, T. Urushida,
T. Yonada, S. Miyamaoto, M. Matsunaga, T. Kubota. S/rizuo/raCify M.spita/,
Shizuoka, Japan
Implication of asymptomatic pracordial T wave changes after anterior acute
myocardial infarction (AMI) were evaluated in 84 patients who receivedemer-
gent angiography with reparfusion therapy. ECG recordings were obtained
tiicea day for a week. Patients were divided into those without Twave inver-
sion after reperfusion therapy, those who showad normalization of invertad
T wave in convalescent phase of AMI and those without normalization of
invertad T wave. Left ventricular ejection fraction (LVEF), % systolic short-
ening of infarct-related segment (%SS), left ventricular end-diastolic volume
index (EDVI) and patency of the infarct-related artery were evaluated in
angiography’on admission and at 1 month of AMi.
T wave inversion was noted in 74 of 84 patients. Normalization of invertad
T wave was seen in 49 of the 74 patienta at 82 + 32 hours after onset of AMI.
T inversion(–) T normalization(+) T normalization(–)
peak CK (lUil) 6846+ 3765* 4754 &2547# 2123+ 1031
On admission
LVEF (%) 40+5” 44 +9# 55* 16
%ss -1,6+ 1.9$ 6.1 &6.9# 13.1 * 10.1
EDVI 101 * 11” 92& 16 84*2O
1 monthafter AMI
LVEF (%) 38& 9* 46* 13# 56 k 14
%ss 2.7& 5.9* 10.4+ 8,ti 19.2 + 6.6
EDVI 129 + 20” 92& 17 65& 16
Coronaty reoeclueion 2/10 (20%) 5/49 (lo%) 4/25 (16%)
*p< 0.05 veothers, #p < 0.05va T nOrmalizstiOn(–)
Thus, absence of T wave invereion after reperfusion therapy was as-
sociated with the largest infarction. Infarction waa larger in patients with
normalization of invertad T wave than in thoae without normalization. T wave
changes were not associated with coronary raoeelusiort.UprightTwave may
l“
be a sign of left ventricular remodeling or profounder myoeardial damage.
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P.B.Amsterdam, G.E. Hafley, R.A. Barrington, C.B. Granger, E.J. Topol,
o R.M. Califf for the GUSTO-llb Investigators. Duke University Msdica/
,
Centec Durham, NC, USA
Studies of acute coronary syndromes (ACS) have shown that STelevation is
highly specific, but less sensitive, for total coronaty oeelusions,particularly of
l the left circumflex (LCX). To further investigate the ECG characteristics and
o outcomes of acute LCXoeelusions, weetudiad patients inthe GUSTO-llbtrial
(of heperin vs. desirudin in ACS) with enzymatic evidence of Ml at enrollment
and the LCX identified astheculpritartery ateardiaceetheterization. Of these,
250 had evidence of LCX occlusion based on ST elevation at presentation,
.
and 1S0 had no ST elevation but LCX occlusion based on 100% stenosis
and/or TIMI c 2 flow. Thus, 41.9% of patients with LCX occlusion and Ml had
no ST elevation. Outcomes for these patiente are shown (table).
n Death at 30 deye, Peek CK-MS, Killipz Ill, LytiesJIQPTCA,
n n (“A) lull n (OA) n (“/.)
ST+ 250 1 (0.4)” not 12 (4.6) 224 (90)
No’ST? 160 8 i4.4i* 71t 15 i6.3i 33 (;6.3)
*p= 0.004;t p = 0.0003
Conclusion: Absence of ST elevation in Ml due to LCX occlusion is
ebmmon. Mortality was significantly higherat30 days in the non-ST-elevation
group, perhape because fewer got reperfusion therapy despite occluded
culprit arteries. More sensitive, noninvasive ways to identify LCX occlusion
(than the 12-lead ECG) should be developad to determine whether these
patients, if identified early, would benefit from repatiusion therapy.
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D1079110 A 8eiectiveUeeofTissuePlaeminogenActivator
and8treptokinasefor AcuteMyocardiai
infarctioniaMoreCoat-affectiveThanthe
ExclusiveUeeofTissuePlasminogenActivator
R. Lorenzoni, G. Fattore, G. Gensini. Inst. of Cwdio/ogy, Universifyof
F/orenceand Bocconi Univerei~ Milan, Italy
Thrombolysis in acute myocardial infarction (AMI) with tissue plasminogen
activator (tPA) is eoet-effactive in respect to the use of streptokineee (SK).
Aim of this refxxl istotest the cost-effectiveness of aseleetive use of SKand
tPA for the treatment of AMI. Methods: We testad two alternative protocols.
Protoco/ A: tPA in patients agad c 75 yeare, SK in patients aged z 75
yeare. Protoco/B:tPA in patienta with anterior AMI, SK in patients with other
AMI. The mats for the two thrombolytic strategies are those repotted for
GUSTO trial: tPA 2.216 and SK 270 US $/treatment; no additional coats
were Computed.Thirly-day mortality ratee and distribution in subgroups (in
brackets after each subgroup) are those repotied in the GUSTO trial: tPA
6.3% and SK 7.3% for the general population; tPA 4.4% in patients agad <
75 yeare (88Y.), SK 20.6% in patients agad ? 75 years (12%); tPA 8.6% in
patients with anterior AMI (39%), SK 5.3% in patients with other AMI (61%).
Resu/te.’Data are for 1.000 patients treated and rests are expressad in US
$. The exclusive use of SK costs 270.000 with 73 deaths. Costs, deaths,
and costs for each extra life saved with the exclusive use of tPA and the
use of protocol A and B in respect to the exclusive use of SK, are shown in
tabie.
costs Deaths Cost/lifesaved
tPA 2,216,000 63 t94,600
ProtocolA 1,962,480 64 190,276
ProtocolB i.02s.e40 65 e4.s67
Therefore, the cost of each extra life saved (2 life saved every 1.000
patients treatad) with the exclusive use of tPA inetead of the use of protccol
B would be 593.530. Conclusions: The use of tPA in anterior AMI and SK in
other AMI could be more cost-effective than the exclusive uae of tPA.
W1’ThrombinGeneration~urin9Thr m~oiYaiawi~~
rt-PAandConjunctiveTherapyWithr-Hirudinin
PatientsWithAcuteMyocardiaiInfarction
U. Zeymer, M. Mateblowski, K.-L. Neuhaus. SWffische K/iniken Kaase/,
Germany
Thrombolytic therapy is known to induce not only Iysis of thrombi but also
proeoagulant effects. Thrombin is one of the most important factors invoivad
in the pethogenesis of acute corona~ syndromes. We determined thrombin
generation in 17 patients with acute myoeardial infarction before, during and
after thrombolyeis with front-loaded rt-PA (100 m@O rein) and conjunctive
therapy with raeombinant hirudin (HBW 023; bolus of 0.4 mg/kg, infusion of
0.15 mg/k@h over 46 houm). Pro-thrombin fragment 1.2 (F1.2), thrombin-
antithrombin Ill complex (TAT) and free r-hirudin plaama levels (Hir) were
determined at baseline (before), during (30 and 80 rein) and after (4 and 24
h) thrombolysis. Mean values+ SD are shown in the table.
